These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33428244)

  • 21. Targeting the tick-pathogen interface for novel control strategies.
    de la Fuente J; Kocan KM; Almazan C; Blouin EF
    Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tick Saliva and Salivary Glands: What Do We Know So Far on Their Role in Arthropod Blood Feeding and Pathogen Transmission.
    Neelakanta G; Sultana H
    Front Cell Infect Microbiol; 2021; 11():816547. PubMed ID: 35127563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tick-Borne Viruses and Biological Processes at the Tick-Host-Virus Interface.
    Kazimírová M; Thangamani S; Bartíková P; Hermance M; Holíková V; Štibrániová I; Nuttall PA
    Front Cell Infect Microbiol; 2017; 7():339. PubMed ID: 28798904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: Tick-Host-Pathogen Interactions.
    Bonnet SI; Nijhof AM; de la Fuente J
    Front Cell Infect Microbiol; 2018; 8():194. PubMed ID: 29963500
    [No Abstract]   [Full Text] [Related]  

  • 26. How ticks keep ticking in the adversity of host immune reactions.
    Jennings R; Kuang Y; Thieme HR; Wu J; Wu X
    J Math Biol; 2019 Apr; 78(5):1331-1364. PubMed ID: 30478760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional Immunoprofiling at the Tick-Virus-Host Interface during Early Stages of Tick-Borne Encephalitis Virus Transmission.
    Thangamani S; Hermance ME; Santos RI; Slovak M; Heinze D; Widen SG; Kazimirova M
    Front Cell Infect Microbiol; 2017; 7():494. PubMed ID: 29250492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.
    Nuttall PA; Trimnell AR; Kazimirova M; Labuda M
    Parasite Immunol; 2006 Apr; 28(4):155-63. PubMed ID: 16542317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tick-host interactions: saliva-activated transmission.
    Nuttall PA; Labuda M
    Parasitology; 2004; 129 Suppl():S177-89. PubMed ID: 15938511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Alpha-Gal-Containing Antigens in North American Tick Species Believed to Induce Red Meat Allergy.
    Crispell G; Commins SP; Archer-Hartman SA; Choudhary S; Dharmarajan G; Azadi P; Karim S
    Front Immunol; 2019; 10():1056. PubMed ID: 31156631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serine Protease Inhibitors in Ticks: An Overview of Their Role in Tick Biology and Tick-Borne Pathogen Transmission.
    Blisnick AA; Foulon T; Bonnet SI
    Front Cell Infect Microbiol; 2017; 7():199. PubMed ID: 28589099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective.
    González-Cueto E; de la Fuente J; López-Camacho C
    Front Immunol; 2024; 15():1384442. PubMed ID: 38947333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and control strategies for ticks and pathogen transmission.
    de La Fuente J; Kocan KM; Contreras M
    Rev Sci Tech; 2015 Apr; 34(1):249-64. PubMed ID: 26470461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for development of vaccines for control of ixodid tick species.
    de la Fuente J; Kocan KM
    Parasite Immunol; 2006 Jul; 28(7):275-83. PubMed ID: 16842264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines against tick-borne diseases: a big step forward?
    Boulanger N; Wikel S
    Trends Parasitol; 2023 Dec; 39(12):989-990. PubMed ID: 37838513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ticks and tick-borne pathogens at the cutaneous interface: host defenses, tick countermeasures, and a suitable environment for pathogen establishment.
    Wikel S
    Front Microbiol; 2013 Nov; 4():337. PubMed ID: 24312085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upcoming and future strategies of tick control: a review.
    Ghosh S; Azhahianambi P; Yadav MP
    J Vector Borne Dis; 2007 Jun; 44(2):79-89. PubMed ID: 17722860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.
    Sprong H; Trentelman J; Seemann I; Grubhoffer L; Rego RO; Hajdušek O; Kopáček P; Šíma R; Nijhof AM; Anguita J; Winter P; Rotter B; Havlíková S; Klempa B; Schetters TP; Hovius JW
    Parasit Vectors; 2014 Feb; 7():77. PubMed ID: 24559082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.